Who owns TRANSCODE THERAPEUTICS INC?
- Ticker: RNAZ
- CUSIP Number: 89357l501
Tip: Access positions for across all investors
Analyze quarterly positions in Transcode Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Transcode Therapeutics stock
Who bought or sold TRANSCODE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 13k | $110k | 100% | Mar 2026 |
|
| UBS Group | 8.3k | $71k | 180% | Mar 2026 |
|
| Vanguard Capital Management | 6.5k | $56k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 3.0k | $26k | 100% | Mar 2026 |
|
| Tower Research Capital | 887.00 | $6.1k | 525% | Dec 2025 |
|
| Wells Fargo & Company | 55.00 | $474.001000 | 100% | Mar 2026 |
|
| SBI Securities | 12.00 | $102.999600 | 20% | Mar 2026 |
|
| Royal Bank of Canada | 8.00 | $0 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 3.00 | $20.000100 | 0% | Dec 2025 |
|